Objective To investigate the impact of death-associated protein kinase 1 (Dapk1) on
lipopolysaccharide (LPS)-induced acute lung injury (ALI) via p38MAPK/NF-κB pathway …

Lung ischemia-reperfusion (I/R) injury remains one of the most common complications after
various cardiopulmonary surgeries. The inflammation response triggered by the released …

The purpose of this study was to investigate the protective effect of PD against
lipopolysaccharide (LPS)-induced acute lung injury (ALI) and explore its potential …

Acute lung injury (ALI) is a serious complication of sepsis and an important cause of death in
intensive care. Studies have shown that DEX can inhibit inflammation. However, the anti …

Acute lung injury (ALI) is a common clinical condition with a high mortality rate and no
specific treatment is available. An excessive inflammatory response contributes to the …

Lipopolysaccharide (LPS) has been known to cause alveolar epithelial cell (AEC) apoptosis
and barrier breakdown that characterize acute lung injury (ALI) and acute respiratory …

Programmed death ligand 1 (PD-L1) is not only an important molecule in mediating tumor
immune escape, but also regulates inflammation development. Here we showed that PD-L1 …

The protective effects of dioscin, a natural steroidal saponin from some medicinal plants
including Dioscorea nipponica Makino, against lipopolysaccharide (LPS)-induced acute …

Acute lung injury (ALI) is a common lung disease accompanied by acute and persistent
pulmonary inflammatory response syndrome, which leads to alveolar epithelial cells and …

Oxidative stress is considered one of the early underlying contributors of acute lung injury
(ALI) and ventilator-induced lung injury (VILI). DJ-1, also known as PARK7, has a well …